- Home
- DAVA vs PRME Comparison
DAVA vs PRME Comparison
Compare DAVA & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAVA
- PRME
- Stock Information
- Founded
- DAVA 2000
- PRME 2019
- Country
- DAVA United Kingdom
- PRME United States
- Employees
- DAVA N/A
- PRME N/A
- Industry
- DAVA EDP Services
- PRME Medicinal Chemicals and Botanical Products
- Sector
- DAVA Technology
- PRME Health Care
- Exchange
- DAVA Nasdaq
- PRME Nasdaq
- Market Cap
- DAVA 761.0M
- PRME 624.0M
- IPO Year
- DAVA 2018
- PRME 2022
- Fundamental
- Price
- DAVA $10.04
- PRME $3.99
- Analyst Decision
- DAVA Buy
- PRME Buy
- Analyst Count
- DAVA 9
- PRME 6
- Target Price
- DAVA $22.89
- PRME $8.88
- AVG Volume (30 Days)
- DAVA 1.6M
- PRME 2.9M
- Earning Date
- DAVA 09-04-2025
- PRME 11-11-2025
- Dividend Yield
- DAVA N/A
- PRME N/A
- EPS Growth
- DAVA 24.14
- PRME N/A
- EPS
- DAVA 0.49
- PRME N/A
- Revenue
- DAVA $1,058,028,497.00
- PRME $4,961,000.00
- Revenue This Year
- DAVA $1.48
- PRME $179.58
- Revenue Next Year
- DAVA $5.38
- PRME N/A
- P/E Ratio
- DAVA $19.06
- PRME N/A
- Revenue Growth
- DAVA 4.25
- PRME 739.42
- 52 Week Low
- DAVA $9.34
- PRME $1.11
- 52 Week High
- DAVA $34.94
- PRME $5.17
- Technical
- Relative Strength Index (RSI)
- DAVA 33.82
- PRME 56.90
- Support Level
- DAVA $9.34
- PRME $3.09
- Resistance Level
- DAVA $10.12
- PRME $4.18
- Average True Range (ATR)
- DAVA 0.56
- PRME 0.26
- MACD
- DAVA -0.37
- PRME 0.08
- Stochastic Oscillator
- DAVA 12.43
- PRME 82.11
About DAVA Endava plc (each representing one)
Endava is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2006 in the UK and it continues to generate the majority of revenue in the UK and Europe. Endava's client base is concentrated in the payments and financial services, technology, media, and telecom industries.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.